Page last updated: 2024-10-25

ciglitazone and Diabetic Angiopathies

ciglitazone has been researched along with Diabetic Angiopathies in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verrier, E1
Wang, L1
Wadham, C1
Albanese, N1
Hahn, C1
Gamble, JR1
Chatterjee, VK1
Vadas, MA1
Xia, P1

Other Studies

1 other study available for ciglitazone and Diabetic Angiopathies

ArticleYear
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase.
    Circulation research, 2004, Jun-11, Volume: 94, Issue:11

    Topics: Animals; Aorta; Cattle; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Chromans; Diabetic

2004